Prelude Therapeutics Inc - PRLD - stock price prediction, stock price target, analyst ratings from 4 analysts

Prelude Therapeutics Inc has a share price target of US$ 4 and profit growth estimate of 4.0% for Unknown Year, based on top 4 analyst calls.